Literature DB >> 9285545

Management of thrombotic microangiopathy following allogeneic transplantation: what is the role of plasma exchange?

P Llamas1, R Romero, R Cabrera, I Sanjuán, R Forés, M N Fernández.   

Abstract

Thrombotic microangiopathy (TMA) is an infrequent but serious complication of allogeneic transplantation. The success rate of plasma exchange (PE) reported in the treatment of this entity is a controversial subject. We report the outcome of 10 patients with TMA post-allogeneic transplantation after treatment with PE. Two out of the 10 patients have not responded, five had a partial response, but died of acute GVHD or interstitial pneumonitis, and three have responded and recovered. Our study suggests that there are different degrees of TMA severity. Only mild multifactorial cases with no severe hemolysis (LDH activity <1000 U/l) may be fully resolved with PE.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9285545     DOI: 10.1038/sj.bmt.1700889

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

Review 1.  Allogeneic reactivity-mediated endothelial cell complications after HSCT: a plea for consensual definitions.

Authors:  Simona Pagliuca; David Michonneau; Flore Sicre de Fontbrune; Aurélien Sutra Del Galy; Aliénor Xhaard; Marie Robin; Régis Peffault de Latour; Gérard Socie
Journal:  Blood Adv       Date:  2019-08-13

2.  Thrombotic microangiopathy-like disorder after living-donor liver transplantation: a single-center experience in Japan.

Authors:  Tomohide Hori; Toshimi Kaido; Fumitaka Oike; Yasuhiro Ogura; Kohei Ogawa; Yukihide Yonekawa; Koichiro Hata; Yoshiya Kawaguchi; Mikiko Ueda; Akira Mori; Hajime Segawa; Kimiko Yurugi; Yasutsugu Takada; Hiroto Egawa; Atsushi Yoshizawa; Takuma Kato; Kanako Saito; Linan Wang; Mie Torii; Feng Chen; Ann-Marie T Baine; Lindsay B Gardner; Shinji Uemoto
Journal:  World J Gastroenterol       Date:  2011-04-14       Impact factor: 5.742

Review 3.  Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment.

Authors:  Cecilia M Choi; Alvin H Schmaier; Michael R Snell; Hillard M Lazarus
Journal:  Drugs       Date:  2009       Impact factor: 9.546

4.  Eculizumab Treatment in a Patient with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy and Steroid-Refractory Acute Graft Versus Host Disease.

Authors:  Cristina Fernández; Ana Lario; Rafael Forés; Rafael Cabrera
Journal:  Hematol Rep       Date:  2015-12-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.